BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36878996)

  • 1. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
    Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
    Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2016 Mar; 40(3):491-6. PubMed ID: 26853538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.
    Prisciandaro JJ; Hoffman M; Brown TR; Voronin K; Book S; Bristol E; Anton RF
    Am J Psychiatry; 2021 Sep; 178(9):829-837. PubMed ID: 34256607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.
    Prisciandaro JJ; Schacht JP; Prescot AP; Brenner HM; Renshaw PF; Brown TR; Anton RF
    Addict Biol; 2020 Nov; 25(6):e12810. PubMed ID: 31373138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
    Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
    Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-modal neuroimaging reveals differences in alcohol-cue reactivity but not neurometabolite concentrations in adolescents who drink alcohol.
    Kirkland AE; Green R; Browning BD; Aghamoosa S; Meyerhoff DJ; Ferguson PL; Tomko RL; Gray KM; Squeglia LM
    Drug Alcohol Depend; 2024 Apr; 257():111254. PubMed ID: 38457964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine reduces cocaine-seeking behavior and anterior cingulate glutamate/glutamine levels among cocaine-dependent individuals.
    Woodcock EA; Lundahl LH; Khatib D; Stanley JA; Greenwald MK
    Addict Biol; 2021 Mar; 26(2):e12900. PubMed ID: 32212237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
    Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
    Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
    McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial.
    Schulte M; Goudriaan AE; Kaag AM; Kooi DP; van den Brink W; Wiers RW; Schmaal L
    J Psychopharmacol; 2017 Oct; 31(10):1377-1379. PubMed ID: 28922968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
    Morley KC; Peruch S; Adams C; Towers E; Tremonti C; Watt J; Jamshidi N; Haber PS
    Alcohol Alcohol; 2023 Sep; 58(5):553-560. PubMed ID: 37465907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
    Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
    Girgis RR; Baker S; Mao X; Gil R; Javitt DC; Kantrowitz JT; Gu M; Spielman DM; Ojeil N; Xu X; Abi-Dargham A; Shungu DC; Kegeles LS
    Psychiatry Res; 2019 May; 275():78-85. PubMed ID: 30884334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.
    Back SE; Gray K; Santa Ana E; Jones JL; Jarnecke AM; Joseph JE; Prisciandaro J; Killeen T; Brown DG; Taimina L; Compean E; Malcolm R; Flanagan JC; Kalivas PW
    Contemp Clin Trials; 2020 Apr; 91():105961. PubMed ID: 32087337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.
    Prisciandaro JJ; Mellick W; Squeglia LM; Hix S; Arnold L; Tolliver BK
    Addict Biol; 2022 Jan; 27(1):e13085. PubMed ID: 34390300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol.
    Stoops WW; Strickland JC; Hays LR; Rayapati AO; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2020 Nov; 198():173037. PubMed ID: 32891709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder.
    Grodin EN; Burnette EM; O'Neill J; Alger J; Ray LA
    Alcohol Alcohol; 2023 May; 58(3):289-297. PubMed ID: 36939375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine on neural alcohol cue reactivity and craving in adolescents who drink heavily: A preliminary randomized clinical trial.
    Green R; Kirkland AE; Browning BD; Ferguson PL; Gray KM; Squeglia LM
    Alcohol Clin Exp Res (Hoboken); 2024 Jul; ():. PubMed ID: 38960894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior cingulate metabolite levels, memory, and inhibitory control in abstinent men and women with alcohol use disorder.
    Oot EN; Sawyer KS; Oscar-Berman M; Luhar RB; Jensen JE; Silveri MM
    Alcohol Alcohol; 2023 Nov; 58(6):578-588. PubMed ID: 37738108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.